Treatment Against Leukemia ~ Leukemia is a malignant disease that originates from the bone marrow level. Leukemia refers to incomplete development of the number of white blood cells that accumulate in the bone marrow and into the bloodstream. dysfunctional cells multiply abnormally fast rate, possibly exceeding their normal healthy counterparts. Unlike normal cells, the replica cells are incomplete and can not play its role within the organization. Furthermore, it affects the production of the body's normal cells, causing a decrease in the number of white blood cells, red blood cells and platelets.
Leukemia also is classified according to the type of cells involved in causing the disease. Judging by the type of cells responsible for causing cancer, myeloid leukemia or lymphoid can be. Acute leukemia has a high growth rate, while chronic leukemia progresses slowly.
The treatment of leukemia involves a number of cancer treatments and prolonged course of medication against cancer. Given that there is no cure for leukemia here, treatment outcomes are available float. the responsiveness of patients with leukemia therapies and treatments are strongly influenced by age, sex, type of leukemia, and rapid medical intervention. Early diagnosis and prompt treatment, greatly improve the chances of complete recovery.
An interesting aspect is that leukemia affects mainly Caucasians. Although the disease can occur in people belonging to an ethnic group, leukemia is more common in Caucasians. Moreover, a complete remission of leukemia is strongly influenced by the race. Although leukemia is less likely to occur in non-Caucasians, this category of people is much less susceptible to cancer treatment. To detect specific genetic factors responsible for generating different responses for the treatment of leukemia, medical scientists have conducted various studies in the past decade.
Medical scientists have found that patients with acute myeloid leukemia with cytogenetic abnormalities tend to respond much better to treatment than patients without these genetic defects. The category of patients with certain cytogenetic abnormalities were more likely to achieve complete remission after the treatment of leukemia. Doctors and scientists have turned to low reactivity of leukemia treatment, the presence of 8-21 cytogenetic translocations in patients or the absence of any genetic abnormality. Patients who called reverse 16 cytogenetic translocations often respond much better to the treatment of leukemia.
Medical scientists argue that these results will not determine the marked changes in the treatment of leukemia. Scientists believe that in the future people diagnosed with leukemia receive personalized treatments, depending on their age, gender and ethnicity.